[Adverse effects of antiviral agents].
Moriuchi
Masako
M
Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Biomedical Sciences.
Moriuchi
Hiroyuki
H
D000212:Acyclovir / Q000009:adverse effects; D000547:Amantadine / Q000009:adverse effects; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D015658:HIV Infections / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy; D006562:Herpes Zoster / Q000188:drug therapy; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy; D053139:Oseltamivir / Q000009:adverse effects; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D053139:Oseltamivir; D000547:Amantadine; D000212:Acyclovir